financetom
Business
financetom
/
Business
/
MercadoLibre's fourth-quarter net profit beats forecast, shares jump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MercadoLibre's fourth-quarter net profit beats forecast, shares jump
Feb 20, 2025 5:33 PM

SAO PAULO (Reuters) -Latin American e-commerce giant MercadoLibre posted a better-than-expected quarterly net profit on Thursday, up nearly four-fold from the same period a year earlier and sending its shares up more than 12% in after-hours trading.

MercadoLibre, Latin America's largest company by market value, said net income for the October-to-December quarter came in at $639 million, up 287% year-on-year and well above the $401.5 million expected by analysts in an LSEG poll.

Chief Financial Officer Martin de los Santos told Reuters the results reflected lower funding costs and improved logistics efficiency, particularly in Mexico, as well as lower losses with currency, especially in Argentina.

MercadoLibre's net revenue came in at $6.1 billion, up 37% year-on-year and above estimates of $5.9 billion, with sales measured by gross merchandise volume rising 8% year-on-year, driven by 32% growth in its main market Brazil on a foreign exchange-neutral basis.

New York-listed shares of MercadoLibre jumped nearly 13% in post-market trade to about $2,380.

"A solid beat with higher top line and much better margins," Jefferies analysts wrote in a note to clients.

MercadoLibre's shares had fallen after a quarterly miss in November, with analysts citing higher logistic investments and credit ramp-up.

"Margins for a company that don't go in a straight line are sometimes hard to predict from the outside," de los Santos said on Thursday.

"We are trying to convey to the market that we will not shy away from investing in growth opportunities," he added, noting management believes this will make the company able to dilute fixed costs in the long term and continue being profitable.

Its earnings before interest and taxes came in at $820 million in the quarter ended in December, above analysts' expectations of $612 million and up 144% from a year earlier, when results were hurt by a tax hit in the fourth quarter.

MercadoLibre's credit portfolio also rose, reaching $6.6 billion from $6 billion in September, while its 90-day-plus default ratio fell to 17.5% from 17.9% in the period.

Osvaldo Gimenez, head of MercadoLibre's fintech arm, said in a call with analysts that the company has taken some measures, including reducing the issuance of some credit card segments in Brazil and Mexico, to reduce risk at the margin level.

"Essentially, we're being a little bit more cautious," Gimenez said, noting the decision in Brazil was based on a weaker macroeconomic outlook and a rise in interest rates.

"Management comments on credit performance remain reassuring, with limited measures to reduce risk in specific tiers," the Jefferies analysts said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Annovis Bio Files Patents for Combination Therapies Using Buntanetap
Annovis Bio Files Patents for Combination Therapies Using Buntanetap
Oct 2, 2024
02:21 PM EDT, 09/30/2024 (MT Newswires) -- Annovis Bio ( ANVS ) said Monday it filed three new patents for combination therapies involving its lead compound buntanetap with Trulicity or Viagra, or both. The therapies aim to treat neurodegenerative diseases, including Alzheimer's and Parkinson's, the company said, adding that early data shows potential cognitive improvement in preclinical studies using these...
BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq
BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq
Oct 2, 2024
Sept 30 (Reuters) - Linqto: * LINQTO: PREPARING A REGISTRATION STATEMENT TO FILE FOR A POTENTIAL IPO LISTING ON NASDAQ Source text for Eikon: ...
US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
Oct 2, 2024
02:26 PM EDT, 09/30/2024 (MT Newswires) -- Bristol-Myers Squibb Company ( BMY ) won a dismissal of a $6.4 billion lawsuit alleging it delayed a Federal Drug Administration approval process for a Celgene drug in order to avoid paying Celgene shareholders for meeting certain milestones. As part of its deal to acquire Celgene, Bristol-Myers Squibb ( BMY ) issued Celgene...
Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports
Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports
Oct 2, 2024
Sept 30 (Reuters) - U.S.-based asset manager TPG is close to finalizing a 7 billion euro ($7.80 billion) deal to acquire German metering firm Techem, the Financial Times reported on Monday, citing people familiar with the matter. TPG may reach an agreement to acquire Techem from Switzerland's Partners Group as soon as Monday, FT added. ($1 = 0.8977 euros) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved